Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-9-25
pubmed:abstractText
The persistence of circulating tumor cells (CTC) in breast cancer patients might be associated with stem cell like tumor cells which have been suggested to be the active source of metastatic spread in primary tumors. Furthermore, these cells also may undergo phenotypic changes, known as epithelial-mesenchymal transition (EMT), which allows them to travel to the site of metastasis formation without getting affected by conventional treatment. Here we evaluated 226 blood samples of 39 metastatic breast cancer patients during a follow-up of palliative chemo-, antibody - or hormonal therapy for the expression of the stem cell marker ALDH1 and markers for EMT and correlated these findings with the presence of CTC and response to therapy.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-10623696, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-11282020, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-11410494, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-12189386, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-12604184, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-12657737, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-14680486, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-15151202, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-15254419, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-15294153, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-15328170, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-15709183, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-16120859, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-16319975, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-16782806, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17020960, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17020963, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17217540, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17229949, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17332325, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17349583, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17537911, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17785550, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17873341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-17963511, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18167340, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18371393, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18404148, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18544962, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18679793, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18784658, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18793387, http://linkedlifedata.com/resource/pubmed/commentcorrection/19589136-18822183
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1465-542X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R46
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:19589136-Adult, pubmed-meshheading:19589136-Aged, pubmed-meshheading:19589136-Aldehyde Dehydrogenase, pubmed-meshheading:19589136-Antigens, CD34, pubmed-meshheading:19589136-Antigens, Differentiation, pubmed-meshheading:19589136-Biological Markers, pubmed-meshheading:19589136-Breast Neoplasms, pubmed-meshheading:19589136-Carcinoma, Ductal, Breast, pubmed-meshheading:19589136-Cell Line, Tumor, pubmed-meshheading:19589136-Cell Transdifferentiation, pubmed-meshheading:19589136-Epithelial Cells, pubmed-meshheading:19589136-Female, pubmed-meshheading:19589136-Humans, pubmed-meshheading:19589136-Isoenzymes, pubmed-meshheading:19589136-Mesoderm, pubmed-meshheading:19589136-Middle Aged, pubmed-meshheading:19589136-Neoplasm Proteins, pubmed-meshheading:19589136-Neoplastic Cells, Circulating, pubmed-meshheading:19589136-Neoplastic Stem Cells, pubmed-meshheading:19589136-Ovarian Neoplasms, pubmed-meshheading:19589136-Retinal Dehydrogenase, pubmed-meshheading:19589136-Tumor Markers, Biological, pubmed-meshheading:19589136-Young Adult
pubmed:year
2009
pubmed:articleTitle
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients.
pubmed:affiliation
Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany. bahriye.aktas@uk-essen.de
pubmed:publicationType
Journal Article